文/梧桐兄弟 12月7日，第一创业证券股份有限公司（第一创业，002797）公告，全资子公司第一创业证券承销保荐有限责任公司（"一创投行"）于2025 年12月5日收到中国证 监会江苏监管局《行政处罚事先告知书》。 一创投行涉嫌在鸿达兴业 2019 年可转债项目持续督导期间未勤勉尽责，包括： 未充分核查募集资金投入及归还情况；未按规定发表核查意见，导致出具的相关持 续督导文件存在虚假记载；未按规定履行督促及报告义务。 保荐代表人范本源、宋垚，是一创投行上述违法行为直接负责的主管人员。 江苏证监局拟决定：对第一创业证券承销保荐有限责任公司责令改正，给予警告，没收保荐业务收入 4,245,283.02 元，并处以 12,735,849.06 元罚款；对宋垚、范 本源给予警告，并分别处以 150 万元罚款。券商及2保代合计被罚没19981132元。 第一创业证券股份有限公司（以下简称"公司"）全资子公司第一创业证券承销保荐有限责任公司（以下简称"一创投行"）于2025 年10 月31 日收到中国证券监 督管理委员会（以下简称"中国证监会"）《立案告知书》（证监立案字 0102025023 号）。因一创投行在鸿达兴业 ...

Group 1 - Century Huatong plans to change the use of 1.28 million repurchased shares from equity incentive plans to cancellation, reducing total share capital from 7.428 billion to 7.427 billion shares [2] - Wuliangye adjusts its 2025 investment plan, increasing the number of projects from 19 to 22 and changing the investment amount from 2.586 billion to 2.207 billion yuan [3] - Qingyue Technology is under investigation for suspected financial data fraud, with the possibility of forced delisting if found guilty [4] Group 2 - Kang Enbei's chairman and legal representative resigns due to work adjustments, along with another board member [5] - Tianshan Co. expects a tax payment of approximately 61.86 million yuan to impact its 2025 net profit [6] - Muyuan Foods reports a 20.43% year-on-year decline in November sales revenue from live pigs, totaling 9.39 billion yuan [7] Group 3 - GAC Group's November automobile sales decreased by 9.72% year-on-year, with total sales of 1.797 million vehicles [8] - Western Pastoral's fresh milk production in November increased by 6.3% month-on-month but decreased by 6.47% year-on-year [9] - Gemdale Group's November contracted area fell by 58.50% year-on-year, with a total contracted amount of 1.52 billion yuan [10] Group 4 - Zhenghong Technology reports November sales revenue of 4.5196 million yuan from live pigs, with a year-on-year decline of 21.83% [11] - Wens Foodstuff's November chicken sales reached 118 million birds, generating 3.324 billion yuan in revenue [12] - Meilixin's controlling shareholder plans to increase holdings by no less than 50 million yuan [13] Group 5 - Hongcheng Environment's subsidiary wins an 853 million yuan sewage treatment project [14] - Dongzhu Ecology wins a 397 million yuan environmental project [15] - Xindian Software secures a 54 million yuan project for digital community construction [16] Group 6 - China Chemical announces that its nylon new material project has reached full production [17] - Jiaojian Co. is in discussions regarding overdue payments related to financial products, clarifying that it bears no responsibility for these products [18] - Micron Biotech's product is included in the 2025 National Medical Insurance Directory [19] Group 7 - Yitian Intelligent plans to sell 600 smart computing machines for a total of 1.56 billion yuan [20] - First Venture's subsidiary receives an administrative penalty notice from Jiangsu Securities Regulatory Bureau [21] - China Insurance's vice president is under investigation for serious violations [22] Group 8 - Zhixiang Jintai's monoclonal antibody injection is included in the 2025 National Medical Insurance Directory [23] - Haichuang Pharmaceutical's drug is also included in the National Medical Insurance Directory [24] - Yuanli Co. plans to acquire 49% of Clarimex for 25.56 million USD [25] Group 9 - Betta Pharmaceuticals' products are included in the National Medical Insurance Directory [26] - Tianci Materials' controlling shareholder commits to not reducing holdings for six months [27] - Guanglian Aviation's actual controller has had a detention measure lifted [28] Group 10 - Annie Co. announces a share transfer agreement that will make Shengshi Tianan the controlling shareholder [29] - Double Star New Materials notes uncertainty regarding the sustainability of long-term price increases [30] - ST Tianrui terminates plans for a change in control and resumes trading [31] Group 11 - Guao Technology is planning a change in control, leading to a temporary suspension of its stock [32] - Guangqi Technology's subsidiary signs contracts worth 696 million yuan for the production of metamaterials [33] - Shuoshi Biotech's monkeypox virus detection kit is included in the WHO emergency use list [34]

中经实习记者 孙小琴 记者 夏欣 北京报道 12月7日，第一创业发布公告称，收到中国证监会江苏监管局《行政处罚事先告知书》。 证监会对第一创业全资子公司第一创业证券承销保荐有限责任公司（以下简称"一创投行"）因在鸿达兴 业股份有限公司（以下简称"鸿达兴业"）2019年可转债项目持续督导期间未勤勉尽责，被中国证监会江 苏监管局罚没合计1698.11万元。 具体处罚包括：责令改正、给予警告，没收保荐业务收入424.53万元，并处以1273.58万元罚款；两名保 荐代表人宋某、范某源也被警告，并分别罚款150万元。违规行为涉及未充分核查募集资金使用情况、 出具虚假记载文件以及未按规定履行督促及报告义务。 第一创业方面称已督促整改，并表示该处罚不会对第一创业及一创投行的经营活动、财务状况及偿债能 力造成重大不利影响。鸿达兴业已于去年3月退市，其可转债也已违约。 （编辑：罗辑 审核：夏欣 校对：颜京宁） ...

Core Viewpoint - First Capital's wholly-owned subsidiary, Yi Chuang Investment Bank, was fined a total of 16.98 million yuan by the Jiangsu Securities Regulatory Bureau for failing to diligently perform its continuous supervision duties in the 2019 convertible bond project of Hongda Xingye [1][4][8]. Group 1: Regulatory Actions - On October 31, First Capital announced that Yi Chuang Investment Bank received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to alleged negligence in its supervisory duties related to Hongda Xingye's 2019 convertible bond project [1][9]. - The Jiangsu Securities Regulatory Bureau indicated that Yi Chuang Investment Bank failed to adequately verify the use and repayment of raised funds, did not issue required verification opinions, and neglected its supervisory and reporting obligations [4][12]. - The total penalty for Yi Chuang Investment Bank includes a fine of 12.7359 million yuan and the confiscation of 4.245 million yuan in advisory fees, amounting to approximately 16.98 million yuan [4][12]. Group 2: Impact on First Capital - The administrative penalty does not trigger any major violations that would lead to mandatory delisting under the Shenzhen Stock Exchange rules, and both First Capital and Yi Chuang Investment Bank's operations remain normal [5][12]. - First Capital has urged Yi Chuang Investment Bank to learn from this case, accept the penalties sincerely, and enhance its operational quality and compliance to better serve the capital market [4][12]. Group 3: Background on Hongda Xingye - Hongda Xingye, established in 1991 and controlled by Zhou Yifeng, has faced financial difficulties leading to its stock being delisted on March 18, 2024, after failing to meet debt obligations [6][13]. - The company issued 24.27 billion yuan in convertible bonds in December 2019, but has since encountered significant financial distress, culminating in bankruptcy proceedings [6][13].

Core Viewpoint - First Capital's wholly-owned subsidiary, Yi Chuang Investment Bank, was fined a total of 16.98 million yuan by the Jiangsu Securities Regulatory Bureau for failing to diligently perform its continuous supervision duties in the 2019 convertible bond project of Hongda Xingye [2][4][5]. Group 1: Regulatory Actions - Yi Chuang Investment Bank received a notice of administrative penalty from the Jiangsu Securities Regulatory Bureau, which included a fine of 12.73 million yuan and the confiscation of 4.245 million yuan in sponsorship income, totaling approximately 16.98 million yuan [6][10]. - Two responsible supervisors, Fan Benyuan and Song Yao, were fined 1.5 million yuan each and received warnings for their direct involvement in the violations [6][10]. Group 2: Background of the Case - The violations stemmed from Yi Chuang Investment Bank's role as the sponsor for Hongda Xingye's 2019 convertible bond project, where it allegedly failed to adequately verify the use and repayment of raised funds and issued misleading continuous supervision documents [6][10]. - Hongda Xingye, which was established in 1991 and is controlled by Zhou Yifeng, has faced significant financial difficulties, leading to its stock being delisted and the company entering bankruptcy proceedings [9][10]. Group 3: Industry Implications - The case highlights the regulatory trend of holding intermediary institutions accountable for their supervisory responsibilities, emphasizing the need for diligence in continuous supervision to avoid negligence [4][10]. - The penalties against Yi Chuang Investment Bank serve as a warning to other brokerage firms to enhance their supervisory practices and avoid a focus on sponsorship at the expense of diligent oversight [4][10].

本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 第一创业证券股份有限公司（以下简称"公司"）全资子公司第一创业证券承销保荐有限责任公司（以下 简称"一创投行"）于2025年10月31日收到中国证券监督管理委员会（以下简称"中国证监会"）《立案告 知书》（证监立案字0102025023号）。因一创投行在鸿达兴业股份有限公司2019年可转债项目中涉嫌持 续督导业务未勤勉尽责，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规， 2025年10月29日，中国证监会决定对一创投行立案。 根据当事人违法行为的事实、性质、情节与社会危害程度，结合违法行为跨越新旧《证券法》适用的特 别情形，依据《证券法》第一百八十二条的规定，中国证监会江苏监管局拟决定： 一、对第一创业证券承销保荐有限责任公司责令改正，给予警告，没收保荐业务收入4,245,283.02元， 并处以12,735,849.06元罚款； 二、对宋垚、范本源给予警告，并分别处以150万元罚款。 根据《中华人民共和国行政处罚法》第四十五条、第六十三条、第六十四条和《中国证券监督管理委员 会行政处罚听证 ...

Group 1: Diplomatic Tensions - The Chinese Foreign Ministry responded to Japan's claims of radar illumination by Chinese naval aircraft, asserting that Japan's frequent reconnaissance activities pose a greater risk to maritime security [2][5][6] - China rejected Japan's so-called negotiations and has lodged counter-protests in both Beijing and Tokyo, urging Japan to cease its disruptive actions [2][5][6] Group 2: Pharmaceutical Developments - The 2025 National Medical Insurance Directory has added 114 new drugs, including 50 innovative drugs such as Teriparatide and the domestic ADC drug [7] - The commercial insurance directory now includes five CAR-T cell therapies and two imported Alzheimer's drugs, with CAR-T therapy costing over one million yuan per treatment if paid out of pocket [7] Group 3: Financial Issues in Companies - Xiangyuan Cultural Tourism announced that its actual controller is responsible for the overdue financial products, clarifying that these products are unrelated to the company and it bears no repayment obligations [3][15] - Other companies, including Jiaojian Co. and Haichang Ocean Park, also issued statements regarding the financial product issues [15][16] Group 4: Regulatory Actions - First Capital has received a notice of administrative penalty from the Jiangsu Securities Regulatory Bureau, with potential fines nearing 20 million yuan due to supervisory failures in a past convertible bond project [14] - The rapid investigation and penalty process highlights the increasing regulatory scrutiny in the investment banking sector [14]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 第一创业证券股份有限公司（以下简称"公司"）全资子公司第一创业证券承销保荐有限责任公司（以下 简称"一创投行"）于2025年10月31日收到中国证券监督管理委员会（以下简称"中国证监会"）《立案告 知书》（证监立案字0102025023号）。因一创投行在鸿达兴业股份有限公司2019年可转债项目中涉嫌持 续督导业务未勤勉尽责，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规， 2025年10月29日，中国证监会决定对一创投行立案。 2025年12月5日，一创投行收到中国证监会江苏监管局《行政处罚事先告知书》（苏证监罚字〔2025〕 21号），主要内容如下： 一创投行涉嫌鸿达兴业股份有限公司（以下简称"鸿达兴业"）可转债项目持续督导未勤勉尽责一案，已 调查完毕，依法拟作出行政处罚。 一创投行涉嫌在鸿达兴业2019年可转债项目持续督导期间未勤勉尽责，包括：未充分核查募集资金投入 及归还情况；未按规定发表核查意见，导致出具的相关持续督导文件存在虚假记载； ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 证券代码：002797 证券简称：第一创业 公告编号：2025-068 登录新浪财经APP 搜索【信披】查看更多考评等级 第一创业证券股份有限公司 关于全资子公司收到中国证券监督管理委员会江苏监管局 《行政处罚事先告知书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 第一创业证券股份有限公司（以下简称"公司"）全资子公司第一创业证券承销保荐有限责任公司（以下 简称"一创投行"）于2025年10月31日收到中国证券监督管理委员会（以下简称"中国证监会"）《立案告 知书》（证监立案字0102025023号）。因一创投行在鸿达兴业股份有限公司2019年可转债项目中涉嫌持 续督导业务未勤勉尽责，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规， 2025年10月29日，中国证监会决定对一创投行立案。 2025年12月5日，一创投行收到中国证监会江苏监管局《行政处罚事先告知书》（苏证监罚字〔2025〕 21号），主要内容如下： 一创投行涉嫌鸿达兴业股份有限公司（以下简称 ...

Core Viewpoint - The investment bank Yichuang is facing administrative penalties for failing to diligently supervise the convertible bond project of Hongda Xingye, leading to warnings and fines from regulatory authorities [2][4][5]. Group 1: Administrative Penalties - Yichuang is proposed to be fined a total of 16.98 million yuan, which includes the confiscation of 4.25 million yuan in underwriting income and a fine of 12.74 million yuan [5]. - Two responsible underwriters, Fan Benyuan and Song Yao, are also facing individual fines of 1.5 million yuan each [5]. Group 2: Regulatory Findings - The China Securities Regulatory Commission (CSRC) found that Yichuang failed to adequately verify the use and repayment of raised funds, did not issue required verification opinions, and neglected its supervisory and reporting obligations [4][5]. - The violations are considered to breach the Securities Law of the People's Republic of China, specifically articles related to diligence and responsibility in underwriting [4]. Group 3: Impact on Hongda Xingye - Hongda Xingye, the issuer of the convertible bonds, is expected to default on the repayment of the bonds, which are due on December 16, 2025 [6][7]. - As of the announcement date, Hongda Xingye has not secured the necessary funds for the repayment of the principal and interest of the bonds [7]. - The total issuance of Hongda convertible bonds was 2.427 billion yuan, with 337 million yuan still outstanding and unable to be converted [8].